Importantly, in a murine model of lupus nephritis (NZB X NZW F1 (BWF1)), the treatment with IFN-α reduced the Ang1 expression along the time course of the disease, while the Ang2 levels were up-regulated at the first week of the model (Figure 2D). This evidence concerns the gene IFNA1 and lupus nephritis.